For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View

Sponsor Spike Success.

Altria Matches S&P 500 with Strong Dividend Performance

Aug 17, 2026
Altria Matches S&P 500 with Strong Dividend Performance

Altria has demonstrated resilience in the this year, matching the with a 13% price gain. This performance is particularly noteworthy as it comes alongside a robust 6.5% dividend yield, which has been consistently raised over the past 56 years. In contrast, major tech stocks like Tesla and Meta have faced significant declines, with Tesla down 23% and Meta falling 10%. Altria's stock has outperformed these high-profile names, showcasing its stability in a volatile market.

The company has also announced a $2 billion share buyback program, which further enhances its appeal as a defensive investment. Unlike many tech companies heavily in AI, Altria has no exposure to this sector, reducing its financial risk. Investors seeking safety may find Altria's strong dividend yield and consistent performance attractive, especially as market conditions remain uncertain.

For Your Trading Desk
Trading Journals
Click For Trade View
Desk Accessories
Click For Trade View

Sponsor Spike Success.

Despite its solid financials, Altria faces challenges due to its association with tobacco products, which are linked to significant health risks. The Centers for Disease Control and Prevention (CDC) reports that smoking is responsible for approximately 480,000 deaths annually in the U.S. This stigma may deter some investors, but for those willing to overlook these concerns, Altria offers a compelling investment opportunity.

In its latest quarterly report, Altria's revenue remained flat at $6.1 billion, with diluted earnings per share (EPS) dropping 3% to $1.37. The company has repurchased 5.3 million shares at an average price of $62.78, with $665 million remaining in its buyback program, which is set to expire at the end of 2026. As Altria narrows its full-year guidance, it continues to be viewed as a strong candidate for investors looking for stability in an unpredictable market.

For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View
Trading Journals

Log entries, exits, and the reason you clicked. 'It looked promising' deserves a second look.

Click For Trade View

Sponsor Spike Success.

Recommended for You
CVS Health Faces Earnings Challenges Ahead of 2027
Breaking Market News Nov 13, 2026

CVS Health Faces Earnings Challenges Ahead of 2027

CVS Health has seen a 19% stock return over the past year, outperforming the S&P 500. Despite raising its 2026 outlook and planning a…

For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View
Trading Journals

Log entries, exits, and the reason you clicked. 'It looked promising' deserves a second look.

Click For Trade View
Desk Accessories

Monitor stands and desk organizers for a trading setup with fewer loose ends.

Click For Trade View
Market Microstructure & Order Flow

Books on liquidity, order books, spreads, and trade execution. A closer look at what happens between clicking and getting filled.

Click For Trade View
Algorithmic Trading & Python

Coding and research books for systematic traders. Backtests deserve scrutiny, not a victory lap.

Click For Trade View
Financial Statements & Earnings Research

References for reading earnings reports, cash flow, and balance sheets. The headline rarely brings all the footnotes.

Click For Trade View

Sponsor Spike Success.

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)